UPDATE: JP Morgan Downgrades Celgene On Less Upside, Remains Optimistic On Growth

By: via Benzinga
In a report published Thursday, JP Morgan analyst Geoff Meacham downgraded Celgene (NASDAQ: CELG) from Overweight to Neutral and lowered ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.